Magnetic Resonance Imaging (MRI) stands as a cutting-edge medical imaging modality that revolutionizes our understanding of the human body's internal structures. This non-invasive technique harnesses the synergy of powerful magnets and radio waves to produce highly detailed images, showcasing intricate anatomical details with remarkable precision. By capturing the distinct magnetic properties of different tissues, MRI provides an unparalleled level of clarity in visualizing soft tissues, organs, and joints. What sets MRI apart is its commitment to patient safety. Unlike conventional imaging methods such as X-rays or CT scans, MRI does not expose individuals to ionizing radiation, making it a safer option for repeated examinations. The versatility of MRI extends its diagnostic capabilities across various domains, enabling healthcare professionals to delve into the complexities of the brain, spinal cord, muscles, and joints.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States